POCI vs. PDEX, ZJYL, PROF, CVRX, LUCD, INFU, ICAD, OBIO, MGRM, and MBOT
Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include Pro-Dex (PDEX), Jin Medical International (ZJYL), Profound Medical (PROF), CVRx (CVRX), Lucid Diagnostics (LUCD), InfuSystem (INFU), iCAD (ICAD), Orchestra BioMed (OBIO), Monogram Orthopaedics (MGRM), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry.
Precision Optics vs.
Pro-Dex (NASDAQ:PDEX) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking.
15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 47.5% of Pro-Dex shares are held by insiders. Comparatively, 16.3% of Precision Optics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Precision Optics had 3 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Precision Optics and 1 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.26 beat Precision Optics' score of 0.09 indicating that Pro-Dex is being referred to more favorably in the media.
Pro-Dex received 156 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 61.90% of users gave Pro-Dex an outperform vote while only 0.00% of users gave Precision Optics an outperform vote.
Pro-Dex has a net margin of 11.06% compared to Precision Optics' net margin of -21.46%. Pro-Dex's return on equity of 21.68% beat Precision Optics' return on equity.
Pro-Dex has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.
Pro-Dex has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500.
Pro-Dex currently has a consensus price target of $52.00, suggesting a potential upside of 17.12%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Precision Optics.
Summary
Pro-Dex beats Precision Optics on 17 of the 18 factors compared between the two stocks.
Get Precision Optics News Delivered to You Automatically
Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Precision Optics Competitors List
Related Companies and Tools
This page (NASDAQ:POCI) was last updated on 5/22/2025 by MarketBeat.com Staff